We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO Canada NewsWire SAN DIEGO and TORONTO, Oct. 21, 2014 SAN DIEGO and...
Aptose Biosciences to Present at the 2014 BIO Investor Forum Canada NewsWire SAN DIEGO and TORONTO, Oct. 3, 2014 SAN DIEGO and TORONTO, Oct. 3, 2014 /CNW/ - Aptose Biosciences Inc. (TSX: APS), a...
Aptose Biosciences Announces Reverse Stock Split Canada NewsWire SAN DIEGO and TORONTO, Oct. 1, 2014 SAN DIEGO and TORONTO, Oct. 1, 2014 /CNW/ - Aptose Biosciences Inc. (TSX: APS), a...
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University Canada NewsWire 29, 2014 Expansion of...
Aptose Biosciences to Present at Upcoming Investor Conferences Canada NewsWire SAN DIEGO, CA AND TORONTO, Sept. 25, 2014 SAN DIEGO, CA AND TORONTO, Sept. 25, 2014 /CNW/ - Aptose Biosciences Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
Symbol | Price | Vol. |
---|---|---|
FXIiShares China Large Cap | US$ 32.03 (0.34%) | 64.99M |
YANGDirexion Daily FTSE China Bear 3X Shares New | US$ 4.055 (-1.58%) | 47.43M |
SOXLDirexion Daily Semiconductor Bull 3X Shares | US$ 37.85 (-4.54%) | 45.15M |
KWEBKraneShares CSI China Internet | US$ 33.6751 (3.14%) | 43.83M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | US$ 19.625 (4.39%) | 39.71M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions